![Quiver Logo](/static/img/logo-icon.png)
![SYRS logo](https://quiver-logos.s3.us-east-2.amazonaws.com/syrs.png)
Syros Pharmaceuticals, Inc. Common Stock
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SYRS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of SYRS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SYRS's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to SYRS
Recent picks made for SYRS stock on CNBC
ETFs with the largest estimated holdings in SYRS
Flights by private jets registered to SYRS
![Quiver Logo](/static/img/logo-icon.png)